Evidence map›Paper›PMID 30174214›Full record

ReviewThe lancet. HIV2018

Ethical considerations in global HIV phylogenetic research.

Cordelia E M Coltart, Anne Hoppe, Michael Parker, Liza Dawson, Joseph J Amon, Musonda Simwinga, Gail Geller, Gail Henderson, Oliver Laeyendecker, Joseph D Tucker and 12 more

Abstract readReview
In one paragraph

Review in The lancet. HIV, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Tracking HIV Through Wastewater: Ethical Considerations in Public Health Surveillance.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  6. Review
  7. Article
  8. Proposed approaches for public health surveillance: A literature review for the Canadian National HIV Surveillance Program.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2025
    Article
  9. Action needed to address molecular HIV surveillance ethical concerns.Canadian journal of public health = Revue canadienne de sante publique · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Evaluation of Phylogenetic Methods for Inferring the Direction of Human Immunodeficiency Virus (HIV) Transmission: HIV Prevention Trials Network (HPTN) 052.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Cordelia E M ColtartInstitute for Global Health, University College London, London, UK.
Anne HoppeDivision of Infection and Immunity, University College London, London, UK. Electronic address: a.hoppe@ucl.ac.uk.
Michael ParkerThe Wellcome Centre for Ethics and Humanities (Ethox), Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Liza DawsonDivision of AIDS, National Institutes of Health, Bethesda, MD, USA.
Joseph J AmonWoodrow Wilson School of Public and International Affairs, Princeton University, Princeton, NJ, USA.
Musonda SimwingaZambart, University of Zambia, Lusaka, Zambia.
Gail GellerBerman Institute of Bioethics and School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Gail HendersonCenter for Genomics and Society, Department of Social Medicine, University of North Carolina, Chapel Hill, NC, USA.
Oliver LaeyendeckerNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Joseph D TuckerInstitute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA.
Patrick EbaCommunity Support, Social Justice and Inclusion Department, Geneva, Switzerland; School of Law, University of KwaZulu-Natal, Pietermaritzburg, South Africa.
Vladimir NovitskyDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Anne-Mieke VandammeClinical and Epidemiological Virology, Rega Institute for Medical Research, Department of Microbiology and Immunology, KU Leuven-University of Leuven, Leuven, Belgium; Center for Global Health and Tropical Medicine, Unidade de Microbiologia, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal.
Janet SeeleyAfrica Health Research Institute, KwaZulu-Natal, South Africa; Department of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK.
Gina DallabettaBill & Melinda Gates Foundation, Washington, DC, USA.
Guy HarlingInstitute for Global Health, University College London, London, UK; Africa Health Research Institute, KwaZulu-Natal, South Africa.
M Kate GrabowskiDepartment of Pathology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Department of Rakai Community Cohort Study, Rakai Health Sciences Program, Kalisizo, Uganda.
Peter Godfrey-FaussettJoint United Nations Programme on HIV/AIDS, Geneva, Switzerland; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.
Christophe FraserBig Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Myron S CohenInstitute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA; Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.
Deenan PillayDivision of Infection and Immunity, University College London, London, UK; Africa Health Research Institute, KwaZulu-Natal, South Africa.
Ethics in HIV Phylogenetics Working Group

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)ZIAAI000361 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REDD, ANDREW · 2009 to 2025
$15.8M
Medical Research Council MR/R015600/1NIAID NIH HHS P30 AI050410NIAID NIH HHS P30 AI094189Wellcome TrustWellcome Trust 106551/Z/14/A
6 · The paper itself

Abstract

Phylogenetic analysis of pathogens is an increasingly powerful way to reduce the spread of epidemics, including HIV. As a result, phylogenetic approaches are becoming embedded in public health and research programmes, as well as outbreak responses, presenting unique ethical, legal, and social issues that are not adequately addressed by existing bioethics literature. We formed a multidisciplinary working group to explore the ethical issues arising from the design of, conduct in, and use of results from HIV phylogenetic studies, and to propose recommendations to minimise the associated risks to both individuals and groups. We identified eight key ethical domains, within which we highlighted factors that make HIV phylogenetic research unique. In this Review, we endeavoured to provide a framework to assist researchers, public health practitioners, and funding institutions to ensure that HIV phylogenetic studies are designed, done, and disseminated in an ethical manner. Our conclusions also have broader relevance for pathogen phylogenetics.

Indexed as

PhylogenyBiomedical ResearchGuidelines as TopicHIVHIV InfectionsHuman RightsHumansPublic HealthResearch DesignRisk Assessment

Identifiers

PMID30174214
PMCPMC7327184

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.